Pharmafile Logo

PoTS LIVE: A unique ethnography study in rare disease

Digital ethnography has been deployed with PoTS patients for the first time, by Origins Insights, with significant results for the PoTS UK charity.

During these extremely difficult times, many market research projects have been delayed, postponed or cancelled altogether.  However, one unique project investigating the impact of living with Postural Tachycardia Syndrome (PoTS) has carried on regardless and recently came to a conclusion. PoTS is a chronic health condition that predominantly affects young women. It is a multi-system disorder that causes a wide range of symptoms which vary across patients and can be triggered by a multitude of factors. As such, PoTS can be difficult to manage and affects many different areas of a person’s life, such as their cognition, mobility and general well-being.

This study, which utilised digital ethnographic techniques to gain deep patient insights, is one of the only studies of its kind in PoTS. It is a collaboration initiated by Origins Insights, delivering the project for charity PoTS UK, and supported by trainee clinical psychologist Sam Waterman, from Royal Holloway, University of London.

The study used a longitudinal qualitative approach to look at two specific areas:

  • the psychological impact of PoTS
  • the functional impact of PoTS, including its impact on activities of daily living.

Focused digital ethnography with an unstructured approach to interviewing was used to collect data, through remote filming by participants over a few weeks, even continuing during the height of the COVID-19 pandemic. Data were immediately accessible to analysts, due to use of a centralised research platform, who utilised Interpretative Phenomenological Analysis (IPA) to deliver detailed examinations of personal lived experience.

So what were the findings? Four key themes emerged.

  • Loss of control and lack of agency over their body, e.g. ‘Am I dying?’ – broad and intense impact of symptoms; ‘There will be days where I feel great and those days where I really don’t’ – fluctuating nature of PoTS
  • Identity, e.g. ‘Can I not just be normal?’ – feeling different from others; PoTS ‘is part of my identity’ – accepting PoTS into their identity
  • Lack of understanding from others, e.g. ‘You’ll be fine in a minute’ – others not understanding impact of PoTS; ‘There’s more to life than staying alive’ – medical professionals not understanding PoTS
  • Adapting to cope with PoTS, e.g. ‘Planning my life around PoTS now’ – coping strategies.

Many of these are common challenges across rare diseases, but the power of the methodology came with the audio-visual data provided by participants. This data illustrates the patients’ emotive insights and, moving forward, will be utilised by PoTS UK to inform educational, communications and digital support services across stakeholders for many years to come.

Get in touch with Origins Insights to see and hear more about these immersive, emotive, transformative outcomes.

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Thinking creatively about patient involvement in publications

Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

The value medical communications bring to phase 2/3 of drug development

Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond...

Bedrock expands growing strategy and scientific teams

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Bedrock Healthcare Communications appoints Louise Adamson as Head of Scientific Services

Louise Adamson joins Bedrock as Head of Scientific Services to drive scientific and strategic excellence and grow and develop the scientific team.

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

The award recognises outstanding achievement in flexing thinking and processes to ensure success.